News Release: Research

May 10,  2011

Action Cycling Ride Benefits AIDS Vaccine Research at Emory Vaccine Center

News Article Image

More than 150 bicycle riders will join the two-day, 200-mile AIDS Vaccine 200 (AV200) ride to benefit AIDS vaccine research at the Emory Vaccine Center. The event on May 14-15 is sponsored by Action Cycling Atlanta, a volunteer-run organization.

This year’s ride travels from Emory to Eatonton, Ga. in the Oconee National Forest and back to Emory. Participants include individual riders and relay teams, with support from a volunteer crew.

David Osborn, president of Action Cycling Atlanta, says, “It has been a true pleasure working with such a dedicated group of volunteers and riders another year. We are all excited at the prospect of a record year in terms of funds raised and riders participating. We hope to come very close to $1 million in total fundraising this year.”

This marks the ninth year of the Action Cycling Ride, which thus far has raised $750,000 for AIDS vaccine research, in addition to $28,000 for local HIV/AIDS service organizations. Action Cycling Atlanta has been able to donate 100 percent of all funds raised by participants. These unrestricted funds fill funding gaps that cannot be met through grant dollars alone.

"An effective HIV/AIDS vaccine remains the most challenging and the most essential goal in the world’s fight against this challenging disease,” says Rafi Ahmed, PhD, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar. "Scientists continue to make significant progress in creating vaccines to prevent and treat HIV infection, and the Emory Vaccine Center is at the forefront of this effort.”

The Emory Vaccine Center is one of the largest academic vaccine centers in the world and is renowned for its expertise in cellular immunity and immune memory. A few of the projects that have been supported by Action Cycling's annual AV200 include:

  • Development of one of the world's first preventive AIDS vaccines, and development of a therapeutic vaccine, both currently being tested in human clinical trials.
  • Combating AIDS in Africa through prevention, counseling, and vaccine development and testing.
  • Innovative discoveries about the immune system leading to new strategies designed to fight chronic infections like HIV/AIDS.
  • Testing of potential new HIV/AIDS vaccines at the Hope Clinic of the Emory Vaccine Center in Atlanta as part of the premier National Institutes of Health HIV Vaccine Trials Network.
  • Development of an AIDS vaccine in India at the Vaccine Center’s satellite campus in New Delhi.

For more information about the AV200 bicycle ride, or to donate, visit http://www.actioncycling.org

For more information about the Emory Vaccine Center, visit http://vaccines.emory.edu

###

The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service.

Learn more about Emory’s health sciences:
Blog: http://emoryhealthblog.com
Twitter: @emoryhealthsci
Web: http://emoryhealthsciences.org

News Release Tools

  • Print

News Releases

The news release you are currently viewing is part of an archive of Emory health sciences press releases, dating Sept. 2008 - Dec. 2011.



To View Current Releases


Emory News Center

Emory News Center



To View News Archives


News Archives

News Archives